Eman Ibrahim

Evaluating neoantigen-vaccine responses through mechanistic and model-based frameworks

Ibrahim, Eman; Laurén, Ida; Veerman, Rosanne E.; Jönsson, Siv et al.

Ingår i npj Precision Oncology, 2026

• DOI för Evaluating neoantigen-vaccine responses through mechanistic and model-based frameworks
• Ladda ner fulltext (pdf) av Evaluating neoantigen-vaccine responses through mechanistic and model-based frameworks

Evaluation of sNfL as a biomarker for paclitaxel-induced peripheral neurotoxicity through an integrated PKPD model

Ibrahim, Eman I.K.; Girdenytė, Milda; Hu, Yang; Di Cesare Mannelli, Lorenzo et al.

Ingår i Pharmaceutical research, s. 1071-1088, 2026

• DOI för Evaluation of sNfL as a biomarker for paclitaxel-induced peripheral neurotoxicity through an integrated PKPD model
• Ladda ner fulltext (pdf) av Evaluation of sNfL as a biomarker for paclitaxel-induced peripheral neurotoxicity through an integrated PKPD model

Optimizing Ibrutinib Posology in Chronic Lymphocytic Leukemia Using a Semi-Mechanistic Pharmacometric Framework

Ibrahim, Eman; Friberg, Lena E.

Ingår i CPT, s. 2186-2197, 2025

• DOI för Optimizing Ibrutinib Posology in Chronic Lymphocytic Leukemia Using a Semi-Mechanistic Pharmacometric Framework
• Ladda ner fulltext (pdf) av Optimizing Ibrutinib Posology in Chronic Lymphocytic Leukemia Using a Semi-Mechanistic Pharmacometric Framework

Mechanism-based pharmacometric models to improve the development and use of anticancer therapies

Ibrahim, Eman I. K.

2025

• Ladda ner fulltext (pdf) av Mechanism-based pharmacometric models to improve the development and use of anticancer therapies

Integrated modeling of biomarkers, survival and safety in clinical oncology drug development

Liu, Han; Ibrahim, Eman I.K.; Centanni, Maddalena; Sarr, Céline et al.

Ingår i Advanced Drug Delivery Reviews, 2025

• DOI för Integrated modeling of biomarkers, survival and safety in clinical oncology drug development
• Ladda ner fulltext (pdf) av Integrated modeling of biomarkers, survival and safety in clinical oncology drug development

Evaluating neoantigen-vaccine responses through mechanistic and model-based frameworks

Ibrahim, Eman; Laurén, Ida; Veerman, Rosanne E.; Jönsson, Siv et al.

Ingår i npj Precision Oncology, 2026

• DOI för Evaluating neoantigen-vaccine responses through mechanistic and model-based frameworks
• Ladda ner fulltext (pdf) av Evaluating neoantigen-vaccine responses through mechanistic and model-based frameworks

Evaluation of sNfL as a biomarker for paclitaxel-induced peripheral neurotoxicity through an integrated PKPD model

Ibrahim, Eman I.K.; Girdenytė, Milda; Hu, Yang; Di Cesare Mannelli, Lorenzo et al.

Ingår i Pharmaceutical research, s. 1071-1088, 2026

• DOI för Evaluation of sNfL as a biomarker for paclitaxel-induced peripheral neurotoxicity through an integrated PKPD model
• Ladda ner fulltext (pdf) av Evaluation of sNfL as a biomarker for paclitaxel-induced peripheral neurotoxicity through an integrated PKPD model

Optimizing Ibrutinib Posology in Chronic Lymphocytic Leukemia Using a Semi-Mechanistic Pharmacometric Framework

Ibrahim, Eman; Friberg, Lena E.

Ingår i CPT, s. 2186-2197, 2025

• DOI för Optimizing Ibrutinib Posology in Chronic Lymphocytic Leukemia Using a Semi-Mechanistic Pharmacometric Framework
• Ladda ner fulltext (pdf) av Optimizing Ibrutinib Posology in Chronic Lymphocytic Leukemia Using a Semi-Mechanistic Pharmacometric Framework

Integrated modeling of biomarkers, survival and safety in clinical oncology drug development

Liu, Han; Ibrahim, Eman I.K.; Centanni, Maddalena; Sarr, Céline et al.

Ingår i Advanced Drug Delivery Reviews, 2025

• DOI för Integrated modeling of biomarkers, survival and safety in clinical oncology drug development
• Ladda ner fulltext (pdf) av Integrated modeling of biomarkers, survival and safety in clinical oncology drug development

Bridging responses to a human telomerase reverse transcriptase-based peptide cancer vaccine candidate in a mechanism-based model

Ibrahim, Eman I. K.; Ellingsen, Espen B.; Mangsbo, Sara M.; Friberg, Lena

Ingår i International Immunopharmacology, 2024

• DOI för Bridging responses to a human telomerase reverse transcriptase-based peptide cancer vaccine candidate in a mechanism-based model
• Ladda ner fulltext (pdf) av Bridging responses to a human telomerase reverse transcriptase-based peptide cancer vaccine candidate in a mechanism-based model

Assessment of ibrutinib scheduling on leukocyte, lymph node size and blood pressure dynamics in chronic lymphocytic leukemia through pharmacokinetic-pharmacodynamic models

Ibrahim, Eman; Karlsson, Mats; Friberg, Lena

Ingår i CPT, s. 1305-1318, 2023

• DOI för Assessment of ibrutinib scheduling on leukocyte, lymph node size and blood pressure dynamics in chronic lymphocytic leukemia through pharmacokinetic-pharmacodynamic models
• Ladda ner fulltext (pdf) av Assessment of ibrutinib scheduling on leukocyte, lymph node size and blood pressure dynamics in chronic lymphocytic leukemia through pharmacokinetic-pharmacodynamic models

A Markov model of fibrosis development in nonalcoholic fatty liver disease predicts fibrosis progression in clinical cohorts

Knöchel, Jane; Bergenholm, Linnéa; Ibrahim, Eman; Kechagias, Stergios et al.

Ingår i CPT, s. 2038-2049, 2023

• DOI för A Markov model of fibrosis development in nonalcoholic fatty liver disease predicts fibrosis progression in clinical cohorts
• Ladda ner fulltext (pdf) av A Markov model of fibrosis development in nonalcoholic fatty liver disease predicts fibrosis progression in clinical cohorts

Tissue Type Differences in ABCB1 Expression and Paclitaxel Tissue Pharmacokinetics in Patients With Esophageal Cancer

van Eerden, Ruben A. G.; van Doorn, Leni; de Man, Femke M.; Heersche, Niels et al.

Ingår i Frontiers in Pharmacology, 2021

• DOI för Tissue Type Differences in ABCB1 Expression and Paclitaxel Tissue Pharmacokinetics in Patients With Esophageal Cancer
• Ladda ner fulltext (pdf) av Tissue Type Differences in ABCB1 Expression and Paclitaxel Tissue Pharmacokinetics in Patients With Esophageal Cancer

Effect of Scalp Cooling on the Pharmacokinetics of Paclitaxel

van Doorn, Leni; van Rosmalen, Mandy M.; van der Deure, Wendy M.; Oomen-de Hoop, Esther et al.

Ingår i Cancers, 2021

• DOI för Effect of Scalp Cooling on the Pharmacokinetics of Paclitaxel
• Ladda ner fulltext (pdf) av Effect of Scalp Cooling on the Pharmacokinetics of Paclitaxel

Mechanism-based pharmacometric models to improve the development and use of anticancer therapies

Ibrahim, Eman I. K.

2025

• Ladda ner fulltext (pdf) av Mechanism-based pharmacometric models to improve the development and use of anticancer therapies

Leveraging PKPD modelling and simulation to characterize sNfL dynamics and predict paclitaxel-induced peripheral neurotoxicity in patients

Ibrahim, Eman I. K.; Girdenyté, Milda; Velasco, Roser; Bruna, Jordi et al.

A mechanistic model-informed evaluation of neoantigen-vaccine responses to approaches in synthetic long peptide-based vaccine development

Ibrahim, Eman I. K.; Laurén, Ida; Veerman, Rosanne E.; Jönsson, Siv et al.